A Cross-sectional Study Highlighting Awareness about FDA Announcement on Voluntary Recall of Ranitidine among Physicians and Pharmacists in and Around Chennai, India

Ranitidine is a histamine-2 (H2) blocker that lowers the amount of acid produced by the stomach. The medicine was recalled in September 2019 by the Food and Drug Administration (FDA), the European Medicines Agency (EMA), and Health Canada owing to impurities N-nitrosodimethylamine (NDMA). According to laboratory examinations, NDMA is a carcinogen. The study’s goal is…
Read more

February 18, 2022 0